ScreenerHero

IOT Innovotech Inc.

TSXV · CA · Healthcare · Biotechnology · innovotech.ca
0.0650CAD0.00%Mkt Cap: 2.58M $P/E: —

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap2.58M USD
Enterprise Value2.46M USD
Revenue (TTM)2.71M USD
Gross Profit1.75M USD
Net Income (TTM)68.73K USD
Revenue/Share0.07 CAD
Last Price0.0650 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.31
EV/Revenue0.91
P/S0.95
P/B1.38
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.06500% of range0.2900
52W High0.2900 CAD
52W Low0.0650 CAD
Profitability
Gross Margin52.86%
Oper. Margin-102.56%
EBITDA Margin-17.08%
Profit Margin2.08%
ROE2.62%
ROA2.13%
Growth
Revenue Growth-30.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.41K USD
CapEx (TTM)343.39K USD
FCF Margin-35.08%
FCF Yield-36.89%
Net Debt-153.90K USD
Net Debt/EBITDA0.33
Balance Sheet
Debt/Equity0.04
Current Ratio2.07
Quick Ratio1.59
Book Value/Sh0.05 CAD
Cash/Share0.0070 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.54.44M
Float30.93M
Insiders41.88%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short300
Short (prev mo.)133
Technical
SMA 500.0800 (-18.8%)
SMA 2000.1603 (-59.4%)
Beta1.24
S&P 52W Chg14.58%
Avg Vol (30d)27.27K
Avg Vol (10d)20.18K
Technical Indicators
RSI (14)33.8
MACD-0.0042
MACD Signal-0.0036
MACD Hist.-0.0006
BB Upper0.0856 CAD
BB Middle0.0742 CAD
BB Lower0.0629 CAD
BB Width30.62%
ATR (14)0.0033 CAD
Vol Ratio (20d)6.36x